Aptevo Therapeutics Inc. Quarterly Other Assets, Current in USD from Q4 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Aptevo Therapeutics Inc. quarterly Other Assets, Current history and growth rate from Q4 2016 to Q3 2024.
  • Aptevo Therapeutics Inc. Other Assets, Current for the quarter ending September 30, 2024 was $624K, a 3.85% decline year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $624K -$25K -3.85% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $715K -$49K -6.41% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $691K -$891K -56.3% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $689K -$55K -7.39% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $649K -$9K -1.37% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $764K -$4K -0.52% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $1.58M +$705K +80.4% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $744K -$36K -4.62% Dec 31, 2022 10-K 2024-03-05
Q3 2022 $658K +$649K +7211% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $768K +$702K +1064% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $877K +$794K +957% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $780K +$647K +486% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $9K -$197K -95.6% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $66K -$32K -32.7% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $83K -$1.14M -93.2% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $133K -$27K -16.9% Dec 31, 2020 10-K 2022-03-24
Q3 2020 $206K -$1.29M -86.2% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $98K -$3.07M -96.9% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $1.22M -$2.34M -65.6% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $160K -$3.98M -96.1% Dec 31, 2019 10-K 2021-03-31
Q3 2019 $1.49M -$5.5M -78.7% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $3.17M -$3.97M -55.6% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $3.56M -$3.07M -46.3% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $4.14M -$2.57M -38.3% Dec 31, 2018 10-K 2020-03-25
Q3 2018 $6.99M Sep 30, 2018 10-Q 2018-11-14
Q2 2018 $7.14M Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $6.63M Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $6.71M +$4.68M +231% Dec 31, 2017 10-K 2019-03-18
Q4 2016 $2.03M Dec 31, 2016 10-K 2018-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.